本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Corbus Pharmaceuticals Holdings, Inc.

8.12
-0.1200-1.46%
盤後10.442.32+28.57%19:59 EDT
成交量:234.73萬
成交額:2,074.62萬
市值:1.57億
市盈率:-1.33
高:8.50
開:8.38
低:7.95
收:8.24
52周最高:20.56
52周最低:7.12
股本:1,934.13萬
流通股本:1,741.65萬
量比:3.60
換手率:13.48%
股息:- -
股息率:- -
每股收益(TTM):-6.0889
每股收益(LYR):-5.9000
淨資產收益率:-95.58%
總資產收益率:-53.00%
市淨率:1.54
市盈率(LYR):-1.38

資料載入中...

2024/03/20

[修訂]年度報告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2024/03/18

SEC問詢函

Form CORRESP - Correspondence
2024/03/18

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/03/12

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/12

重要事件披露

Form 8-K - Current report
2024/02/29

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/15

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/14

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/12

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/12

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/09

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/06

重要事件披露

Form 8-K - Current report
2024/02/05

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/05

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/05

重要事件披露

Form 8-K - Current report
2024/02/02

重要事件披露

Form 8-K/A - Current report: [Amend]
2024/02/01

重要事件披露

Form 8-K - Current report
2024/01/31

重要事件披露

Form 8-K - Current report
2024/01/29

重要事件披露

Form 8-K - Current report